11-hydroxy-n-(n-propyl)noraporphine and 11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer

11-hydroxy-n-(n-propyl)noraporphine has been researched along with 11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer in 1 studies

Compound Research Comparison

Studies (11-hydroxy-n-(n-propyl)noraporphine)	Trials (11-hydroxy-n-(n-propyl)noraporphine)	Recent Studies (post-2010) (11-hydroxy-n-(n-propyl)noraporphine)	Studies (11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer)	Trials (11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer)	Recent Studies (post-2010) (11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer)
11	0	2	12	0	2

Protein Interaction Comparison

Protein	Taxonomy	11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer (IC50)
D	Rattus norvegicus (Norway rat)	0.368
D(3) dopamine receptor	Rattus norvegicus (Norway rat)	0.368
D(1B) dopamine receptor	Rattus norvegicus (Norway rat)	0.368
D(4) dopamine receptor	Rattus norvegicus (Norway rat)	0.368
D(2) dopamine receptor	Rattus norvegicus (Norway rat)	0.368

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, B; Guo, L; Liu, Z; Ye, N; Zhang, A; Zhang, H; Zhen, X; Zheng, L; Zhou, S	1

Other Studies

1 other study(ies) available for 11-hydroxy-n-(n-propyl)noraporphine and 11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer

Article	Year
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile. Journal of medicinal chemistry, 2011, Jul-14, Volume: 54, Issue:13 Topics: Animals; Antiparkinson Agents; Aporphines; Binding, Competitive; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Levodopa; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Radioligand Assay; Rats; Receptors, Adrenergic; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship; Thioctic Acid	2011

Article

Year

Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.

Journal of medicinal chemistry, 2011, Jul-14, Volume: 54, Issue:13

Topics: Animals; Antiparkinson Agents; Aporphines; Binding, Competitive; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Levodopa; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Radioligand Assay; Rats; Receptors, Adrenergic; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship; Thioctic Acid

2011